SILBERSHER v. VALEANT PHARMACEUTICALS INT'L

No. 20-16176.

89 F.4th 1154 (2023)

Zachary SILBERSHER, Relator, Plaintiff-Appellant, and United States of America, ex rel.; State of California; State of Colorado; State of Connecticut; State of Delaware; State of Florida; State of Georgia; State of Hawaii; State of Illinois; State of Indiana; State of Iowa; State of Louisiana; State of Maryland; State of Michigan; State of Minnesota; State of Montana; State of Nevada; State of New Hampshire; State of New Jersey; State of New Mexico; State of New York; State of North Carolina; State of Oklahoma; State of Rhode Island; State of Tennessee; State of Texas; State of Vermont; State of Washington; Commonwealth of Massachusetts; Commonwealth of Virginia; District of Columbia, Plaintiffs, v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; Valeant Pharmaceuticals International; Salix Pharmaceuticals, Ltd.; Salix Pharmaceuticals, Inc.; Falk Pharma Gmbh, Defendants-Appellees.

United States Court of Appeals, Ninth Circuit.

Filed August 3, 2023.

Amended January 5, 2024.


Attorney(s) appearing for the Case

Tejinder Singh (argued), Sparacino PLLC, Washington, D.C.; Bret D. Hembd , Herrera Kennedy LLP, Burbank, California; Nicomedes S. Herrera and Andrew M. Purdy , Herrera Kennedy LLP, Oakland, California; Warren T. Burns , Burns Charest LLP, Dallas, Texas; Christopher J. Cormier , Burns Charest LLP, Washington, D.C.; for Plaintiff-Appellant.

Michelle Lo , Assistant United States Attorney; Office of the United States Attorney; San Francisco, California; for Plaintiffs United States of America, States of California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Washington, the Commonwealth of Massachusetts, the Commonwealth of Virginia, and District of Columbia.

Moez M. Kaba (argued), Padraic W. Foran , Daniel C. Sheehan , and Haoxiaohan Cai , Hueston Hennigan LLP, Los Angeles, California; for Defendants-Appellees Valeant Pharmaceuticals International Inc., Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd., and Salix Pharmaceuticals Inc.

Christian E. Mammen (argued), Womble Bond Dickinson (US) LLP, San Francisco, California; Mary W. Bourke and Kristen Cramer , Womble Bond Dickinson (US) LLP, Wilmington, Delaware; for Defendant-Appellee Dr. Falk Pharma GmbH.

Justin T. Berger, Cotchett Pitre & McCarthy LLP, Burlingame, California; Jacklyn DeMar, Taxpayers Against Fraud Education Fund, Washington, D.C.; for Amicus Curiae Taxpayers Against Fraud Education Fund.

Gordon D. Todd, Kimberly A. Leaman, Christopher S. Ross, and Katy (Yin Yee) Ho, Sidley Austin LLP, Washington, D.C.; Jack E. Pace III and Peter J. Carney, White & Case LLP, New York, New York; for Amici Curiae Johnson & Johnson and BTG International Ltd.

Order; Opinion by Judge Sanchez


ORDER

An Amended Opinion is being filed simultaneously with this Order.

Judges Schroeder, Sanchez, and Antoon have voted to deny the petition for panel rehearing. Fed. R. App. P. 40. Judge Sanchez voted to deny the petition for rehearing en banc, and Judges Schroeder and Antoon recommended denying the same. The full court has been advised of the petitions, and no judge has requested to vote on whether to...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases